WO2015035730A1 - Ethyl carbamate hydrolase gene and protein encoded thereby and use thereof - Google Patents

Ethyl carbamate hydrolase gene and protein encoded thereby and use thereof Download PDF

Info

Publication number
WO2015035730A1
WO2015035730A1 PCT/CN2013/090631 CN2013090631W WO2015035730A1 WO 2015035730 A1 WO2015035730 A1 WO 2015035730A1 CN 2013090631 W CN2013090631 W CN 2013090631W WO 2015035730 A1 WO2015035730 A1 WO 2015035730A1
Authority
WO
WIPO (PCT)
Prior art keywords
urethane
gene
hydrolase
hydrolase gene
seq
Prior art date
Application number
PCT/CN2013/090631
Other languages
French (fr)
Chinese (zh)
Inventor
陈坚
方芳
李京京
刘庆涛
堵国成
Original Assignee
江南大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 江南大学 filed Critical 江南大学
Publication of WO2015035730A1 publication Critical patent/WO2015035730A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01001Carboxylesterase (3.1.1.1)

Definitions

  • the invention discloses a urethane hydrolase gene and a protein encoded thereby, in particular a urethane hydrolase gene derived from Bacillus lycopene and a protein encoded thereby.
  • Urethane (English name: urethane or ethyl Carbamate (EC), also known as urethane, urethane, is an intermediate for medicines, pesticides, and fragrances, or a cosolvent for the production of sleeping pills, sedatives, injections, and colorants for printing and dyeing industries. It can also be used in biochemical research.
  • urethane itself can be used as a medicine, has anti-cancer properties, and is used for the treatment of multiple myeloma and chronic leukemia.
  • urethane has a carcinogenic effect. Mainly can cause lung cancer, lymphoma, liver cancer, skin cancer and so on.
  • urethane is widely found in fermented foods (such as bread, yogurt, cheese, soy sauce, etc.) and alcoholic beverages (such as wine, rice wine, cider, and Japanese sake).
  • fermented foods such as bread, yogurt, cheese, soy sauce, etc.
  • alcoholic beverages such as wine, rice wine, cider, and Japanese sake.
  • the body's intake of urethane is mainly through the consumption of alcoholic beverages and food. Urethane has become a factor that can not be ignored influencing human health.
  • the technical problem to be solved by the present invention is to provide a urethane hydrolase gene having a nucleotide sequence of SEQ ID NO: 1 Shown or is the nucleotide sequence encoding the protein of SEQ ID NO: 2.
  • the present invention performs N-terminal sequencing of the urethane hydrolase purified from Bacillus lysine, and the N-terminal 12 amino acid residues are aligned with the NCBI database, and the encoding of the urethane is hydrolyzed by designing specific primers.
  • the gene is amplified by the enzyme and a recombinant vector is constructed to transform the host cell, and the gene is expressed in E. coli. Therefore, the object of the present invention is to provide a urethane hydrolase gene, a recombinant vector containing the same, a recombinant genetic engineering strain transformed by the recombinant vector, and the use thereof in preparing a recombinant urethane hydrolase .
  • the specific technical scheme adopted by the present invention is to pass the N-terminal 12 amino acid residues of the urethane hydrolase which has been sequenced and NCBI.
  • Database alignment designing specific primers based on the alignment results to amplify the target gene and ligating the cloning vector, and sequencing the nucleic acid sequence, such as SEQ ID NO. 1 in the sequence listing. Shown in which the coding sequence (CDS) is terminated from the 1st base of DNA to the 1419th, ATG is the transcription start codon, TAA The transcriptional stop codon is obtained by sequence translation as shown in SEQ ID NO. 2 of the Sequence Listing.
  • CDS coding sequence
  • the urethane hydrolase gene of the present invention may also be encoded by the SEQ in the sequence listing.
  • the other nucleotide sequence of the protein consisting of the amino acid sequence shown by ID NO. 2; and the urethane hydrolase of the present invention is not limited to having SEQ ID NO. 2 in the sequence listing.
  • sequence of the amino acid composition shown may also be a protein derived from SEQ ID NO: 2, which has a substitution, deletion or addition of the amino acid sequence of SEQ ID NO: 2 and one or more amino acid residues, such as at the C terminus and / or N One or several amino acid residues are added or deleted at the end, a fusion tag or the like is added, although the form is modified without changing the enzyme activity of the protein.
  • the urethane hydrolase gene can be obtained from Bacillus lysine (Lysinibacillus) Fusiformis), such as Lysinibacillus fusiformis SCO2.
  • the gene expression vector of the indicated nucleotide sequence is also in the scope of protection of the present invention, which is successfully constructed by ligating the cloned target gene sequence into various gene expression vectors by conventional biotechnological means, and the vector used may be Commercially available plasmids, cosmids, phage, and the like, of which the expression vector pET20b(+) is preferred.
  • Another problem to be solved by the present invention is to construct an engineered strain containing a recombinant gene expression vector, which is to transform the recombinant vector into Escherichia coli, and obtain the recombinant genetic engineering bacteria for induction culture, and the culture solution is separated to obtain recombinant carbamate.
  • the bacterial cell of the ethyl ester hydrolase; specifically, the expression vector containing the urethane hydrolase gene is transformed into the corresponding expression host to construct an exogenous expression system. If the above expression vector pET20b(+)-UH will be constructed
  • the E. coli BL21(DE3) competent cells were transformed into E. coli BL21(DE3)/pET20b(+)-UH exogenous expression system.
  • Another technical problem solved by the present invention is to provide a method for preparing a recombinant urethane hydrolase, which is prepared by transforming a recombinant expression vector into an expression host to construct an expression system, and culturing and expressing under certain conditions to prepare a recombinant urethane hydrolysis.
  • Enzyme the expression host may be a plant, an animal or a bacterium, and the preferred expression host is Escherichia coli, such as the genetically engineered bacteria obtained as described above: E. coli BL21(DE3)/pET20b(+)-UH. The better method is to use E.
  • coli BL2 (DE3)/pET20b(+)-UH
  • Figure 1 is a PCR amplification electropherogram of UH of the present invention, wherein 1 is a PCR amplification product of UH; 2 is DNA Marker (2000 bp, Takara company)
  • Figure 2 is a double-cut analysis map of Nde I and BamH I of plasmid pET20b(+)-UH of the present invention, wherein DNA Marker (5000 bp, Takara); 2 pET20b(+)-UH was digested by Nde I and BamH I.
  • Figure 3 is a genetically engineered strain of the present invention E. coli BL21(DE3)/pET20b(+)-UH SDS-PAGE protein electrophoresis map of the expressed product, wherein 1 is a genetically engineered strain E.coli BL21(DE3)/pET20b(+)-UH non-inducing product; It is the protein molecular weight standard (Biyuntian Company); 3 is the product of genetic engineering bacteria E. coli BL21(DE3)/pET20b(+)-UH induced by IPTG for 15 hours.
  • the molecular cloning technique used is referred to J. Sambrook et al., Guide to Molecular Cloning.
  • restriction enzymes and gel recovery kits used were purchased from Fermentas The company, the specific reaction conditions and methods of use refer to its instructions.
  • the genomic extraction kit was purchased from Omega and used with reference to its instructions.
  • the following commercial plasmids and E. coli are used for gene cloning and expression.
  • E.coli BL21 (DE3) (Novagen, United States)
  • a single colony of Bacillus lysine bacillus activated by streaking on a plate was inoculated into LB liquid medium and cultured for about 15 h. In the logarithmic growth phase, the cells are collected. The genomic DNA is extracted by reference to the genomic extraction kit step. Design specific primers based on protein sequence alignment results, including forward primer 1 and reverse primer 2, forward primer 1 Add Nde I, reverse primer 2 plus BamH I, as follows:
  • Reverse Primer 2 5'-CGG GAT CCT TAG ATA TTA GCA AAA ATA TTT GGT TTT-3'
  • the above specific primers are primers, and the UH enzyme gene is amplified.
  • PCR amplification was performed using the Takara kit, and 34 cycles were amplified using the instructions.
  • the amplification conditions are as follows: step temperature time 1 95 ° C 5 min 2 95 ° C 30 sec 3 55 ° C 30 sec 4 72°C 100 sec 5 72°C 10 min
  • the PCR product was separated on a 0.8% agarose gel and the DNA fragment was recovered to a size of 1.4 kb (see Figure 1). Show), by ligase with pMD19-T The vector was ligated, and the cloning vector pMD19-T-UH was constructed. The ligated product was transformed into Escherichia coli JM109, and the plasmid was extracted by shake flask culture. The enzyme was digested and sent to Shanghai Biotech Co., Ltd. to determine the nucleotide sequence, and the nucleotide sequence table was obtained. As shown in ID NO. 1, it is obtained by triplet codon translation as shown in SEQ ID NO. 2 of the amino acid sequence listing.
  • the cloning vectors pMD19-T-UH and pET20b(+) plasmids were Nde I and BamH I, respectively. After double digestion, the digested products were separated by 0.8% agarose gel electrophoresis, and DNA fragments of 1.4 kb and 3.7 kb were separately recovered, and ligase was ligated to construct pET20b(+)-UH.
  • the expression vector was ligated into E. coli BL21 (DE3) competent cells, and the positive clones were screened by ampicillin plate.
  • the recombinant plasmid was cultured and extracted by Nde I and BamH I. Double enzyme digestion was verified and sent to Shanghai Biotech Co., Ltd. for sequencing, which proved to contain the correct insert (as shown in Figure 2), thus obtaining the exogenous expression system of recombinant urethane hydrolase E. coli BL21(DE3)/pET20b(+)-UH.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Disclosed are an ethyl carbamate hydrolase gene UH and the protein encoded thereby and the use thereof, wherein the gene has the nucleotide sequence as shown by SEQ ID NO.1 and the protein encoded thereby has the amino acid sequence as shown by SEQ ID NO.2. A genetic engineering strain is constructed by using the provided UH gene, and a recombinantly expressed enzyme is obtained therefrom with an enzyme activity of 83.5 U/g of wet bacterial cells.

Description

一种氨基甲酸乙酯水解酶基因及其编码的蛋白质和应用  A urethane hydrolase gene and its encoded protein and application
技术领域Technical field
本发明公开了一种氨基甲酸乙酯水解酶基因及其编码的蛋白质,特别是一种来源于梭形赖氨酸芽孢杆菌的氨基甲酸乙酯水解酶基因及其编码的蛋白质。The invention discloses a urethane hydrolase gene and a protein encoded thereby, in particular a urethane hydrolase gene derived from Bacillus lycopene and a protein encoded thereby.
背景技术Background technique
氨基甲酸乙酯(英文名:urethane 或ethyl carbamate,简称EC)又名乌拉坦、尿烷,是一种医药、农药、香料的中间体,或用于生产安眠药、镇静剂、注射剂的助溶剂和印染工业着色剂,也可用于生物化学研究。此外,尿烷本身可作成药使用,具有抗癌性能,用于治疗多发性骨髓瘤和慢性白血病等。Urethane (English name: urethane or ethyl Carbamate (EC), also known as urethane, urethane, is an intermediate for medicines, pesticides, and fragrances, or a cosolvent for the production of sleeping pills, sedatives, injections, and colorants for printing and dyeing industries. It can also be used in biochemical research. In addition, urethane itself can be used as a medicine, has anti-cancer properties, and is used for the treatment of multiple myeloma and chronic leukemia.
20 世纪40 年代,Nettleship 实验证明了氨基甲酸乙酯具有致癌作用。主要可以引起肺肿瘤、淋巴癌、肝癌、皮肤癌等。氨基甲酸乙酯作为副产物广泛存在于发酵食品(如面包、酸牛奶、乳酪、酱油等)和酒精饮料(如葡萄酒、黄酒、苹果酒和日本清酒等)中。人体摄取氨基甲酸乙酯主要是通过饮用酒精饮料和食物。氨基甲酸乙酯已成为影响人类健康的一个不可忽视的因素。Nettleship in the 1940s Experiments have shown that urethane has a carcinogenic effect. Mainly can cause lung cancer, lymphoma, liver cancer, skin cancer and so on. As a by-product, urethane is widely found in fermented foods (such as bread, yogurt, cheese, soy sauce, etc.) and alcoholic beverages (such as wine, rice wine, cider, and Japanese sake). The body's intake of urethane is mainly through the consumption of alcoholic beverages and food. Urethane has become a factor that can not be ignored influencing human health.
目前各国政府对发酵食品中 EC 的含量已出台相应的限量标准。我国生产的白酒、葡萄酒、酱油等中也广泛存在着氨基甲酸乙酯,这不仅制约我国相关产品的出口,更影响普通消费者的健康 。因此采取有效的方法控制或消除发酵食品或饮料中的氨基甲酸乙酯迫在眉睫。Current governments in the fermented food EC The content has been introduced to the corresponding limit standard. Ethyl urethane is also widely found in liquor, wine, soy sauce, etc. produced in China, which not only restricts the export of related products in China, but also affects the health of ordinary consumers. . Therefore, it is extremely urgent to take effective measures to control or eliminate urethane in fermented foods or beverages.
上世纪 90年代,日本科学家筛选到一些能够降解氨基甲酸乙酯的菌株,例如Bacillus licheniformis、Citrobacter sp.、Micrococcus species 等,能够将氨基甲酸乙酯降解为乙醇、氨 和二氧化碳,将致癌物转变成无毒的有机分子,有效的解决了食品的安全性问题。但野生菌产酶量小、蛋白纯化步骤繁琐、有些为非安全性菌株等原因,一直未在食品工业中广泛应用, 这使得挖掘具有氨基甲酸乙酯水解酶活性的基因、构建高效外源表达体系具有重要的意义。通过基因工程的手段,直接克隆和表达所需的氨基甲酸乙酯水解酶,改变野生菌产酶量不足等问题,为氨基甲酸乙酯水解酶的工业化应用提供了新思路并奠定了基础。In the 1990s, Japanese scientists screened strains that could degrade urethane, such as Bacillus. Licheniformis, Citrobacter sp., Micrococcus species, etc., capable of degrading urethane to ethanol, ammonia And carbon dioxide, turning carcinogens into non-toxic organic molecules, effectively solves the problem of food safety. However, the amount of enzyme produced by wild bacteria is small, the purification step of protein is cumbersome, and some are non-safe strains, etc., and have not been widely used in the food industry. This makes it important to excavate genes with urethane hydrolase activity and to construct efficient exogenous expression systems. By genetic engineering, direct cloning and expression of the desired urethane hydrolase, changing the amount of enzymes produced by wild bacteria, etc., provided a new idea and laid the foundation for the industrial application of urethane hydrolase.
发明内容Summary of the invention
本发明要解决的技术问题为提供一种氨基甲酸乙酯水解酶基因,其核苷酸序列如 SEQ ID NO: 1 所示或为编码SEQ ID NO: 2 所示蛋白质的核苷酸序列。The technical problem to be solved by the present invention is to provide a urethane hydrolase gene having a nucleotide sequence of SEQ ID NO: 1 Shown or is the nucleotide sequence encoding the protein of SEQ ID NO: 2.
本发明通过将纯化自梭形赖氨酸芽孢杆菌的氨基甲酸乙酯水解酶做N端测序,将N端12氨基酸残基与NCBI数据库比对,通过设计特异性引物将编码氨基甲酸乙酯水解酶的基因扩增并构建重组载体转化宿主细胞,对此基因在大肠杆菌中进行表达。因此,本发明的目的是提供一种氨基甲酸乙酯水解酶基因、含有该基因的重组载体、该重组载体转化得到的重组基因工程菌,以及其在制备重组氨基甲酸乙酯水解酶中的应用。The present invention performs N-terminal sequencing of the urethane hydrolase purified from Bacillus lysine, and the N-terminal 12 amino acid residues are aligned with the NCBI database, and the encoding of the urethane is hydrolyzed by designing specific primers. The gene is amplified by the enzyme and a recombinant vector is constructed to transform the host cell, and the gene is expressed in E. coli. Therefore, the object of the present invention is to provide a urethane hydrolase gene, a recombinant vector containing the same, a recombinant genetic engineering strain transformed by the recombinant vector, and the use thereof in preparing a recombinant urethane hydrolase .
本发明采用的具体技术方案是通过将已经测序得到的氨基甲酸乙酯水解酶 N 端12 个氨基酸残基与NCBI 数据库比对,根据比对结果设计特异性引物扩增目的基因并连接克隆载体,测序得到其核酸序列,如序列表中SEQ ID NO.1 所示,其中,其编码序列(CDS)从DNA第1 个碱基起至第1419 个终止,ATG 为转录起始密码子,TAA 为转录终止密码子;通过序列翻译得到如序列表中SEQ ID NO.2 所示。当然,如本领域技术人员所知,本发明氨基甲酸乙酯水解酶基因还可以是编码由序列表中SEQ ID NO.2 所示的氨基酸序列组成的蛋白质的其它核苷酸序列;而本发明的氨基甲酸乙酯水解酶不仅仅限于是具有序列表中SEQ ID NO.2 所示的氨基酸组成的序列,还可以是将序列2中的氨基酸序列经过一个或几个氨基酸残基的取代、缺失或添加且具有相同酶活性的由序列2衍生的蛋白质,比如在C 端和/或N 端添加或缺失一个或数个氨基酸残基,添加融合标签等,虽然在形式上进行修饰但不改变蛋白的酶活。The specific technical scheme adopted by the present invention is to pass the N-terminal 12 amino acid residues of the urethane hydrolase which has been sequenced and NCBI. Database alignment, designing specific primers based on the alignment results to amplify the target gene and ligating the cloning vector, and sequencing the nucleic acid sequence, such as SEQ ID NO. 1 in the sequence listing. Shown in which the coding sequence (CDS) is terminated from the 1st base of DNA to the 1419th, ATG is the transcription start codon, TAA The transcriptional stop codon is obtained by sequence translation as shown in SEQ ID NO. 2 of the Sequence Listing. Of course, as known to those skilled in the art, the urethane hydrolase gene of the present invention may also be encoded by the SEQ in the sequence listing. The other nucleotide sequence of the protein consisting of the amino acid sequence shown by ID NO. 2; and the urethane hydrolase of the present invention is not limited to having SEQ ID NO. 2 in the sequence listing. The sequence of the amino acid composition shown may also be a protein derived from SEQ ID NO: 2, which has a substitution, deletion or addition of the amino acid sequence of SEQ ID NO: 2 and one or more amino acid residues, such as at the C terminus and / or N One or several amino acid residues are added or deleted at the end, a fusion tag or the like is added, although the form is modified without changing the enzyme activity of the protein.
所述氨基甲酸乙酯水解酶基因可得自梭形赖氨酸芽孢杆菌(Lysinibacillus fusiformis),如Lysinibacillus fusiformis SCO2 等菌株。The urethane hydrolase gene can be obtained from Bacillus lysine (Lysinibacillus) Fusiformis), such as Lysinibacillus fusiformis SCO2.
含有 SEQ ID NO.1 所示核苷酸序列的基因表达载体也为本发明的保护范围,其是用常规的生物技术手段将克隆得到的目的基因序列连接入各种基因表达载体而构建成功,该使用的载体可以是市售的质粒、粘粒、噬菌体等,其中优选表达载体pET20b(+)。Contains SEQ ID NO.1 The gene expression vector of the indicated nucleotide sequence is also in the scope of protection of the present invention, which is successfully constructed by ligating the cloned target gene sequence into various gene expression vectors by conventional biotechnological means, and the vector used may be Commercially available plasmids, cosmids, phage, and the like, of which the expression vector pET20b(+) is preferred.
本发明要解决的另一个问题是构建含有重组基因表达载体的工程菌株,其是将所述重组载体转化至大肠杆菌中,获得的重组基因工程菌进行诱导培养,培养液分离得到含有重组氨基甲酸乙酯水解酶的菌体细胞;具体为将含有氨基甲酸乙酯水解酶基因的表达载体转化入相应的表达宿主,构建外源表达体系。如将构建好的上述表达载体pET20b(+)-UH 转化入E. coli BL21(DE3)感受态细胞,构建E. coli BL21(DE3)/pET20b(+)-UH 外源表达体系。Another problem to be solved by the present invention is to construct an engineered strain containing a recombinant gene expression vector, which is to transform the recombinant vector into Escherichia coli, and obtain the recombinant genetic engineering bacteria for induction culture, and the culture solution is separated to obtain recombinant carbamate. The bacterial cell of the ethyl ester hydrolase; specifically, the expression vector containing the urethane hydrolase gene is transformed into the corresponding expression host to construct an exogenous expression system. If the above expression vector pET20b(+)-UH will be constructed The E. coli BL21(DE3) competent cells were transformed into E. coli BL21(DE3)/pET20b(+)-UH exogenous expression system.
本发明的解决的另一个技术问题是提供制备重组氨基甲酸乙酯水解酶的方法,通过将重组表达载体转化表达宿主构建表达体系,在一定条件下培养并表达,制备得到重组氨基甲酸乙酯水解酶。其中,表达宿主可以是植物、动物或细菌等,较优的表达宿主是大肠杆菌,如得到上述构建的基因工程菌:E.coli BL21(DE3)/pET20b(+)-UH。较优的方法是,将E. coli BL2 (DE3)/pET20b(+)-UH 基因工程菌培养到一定菌体浓度(如OD600=0.35-0.8),添加诱导剂(如IPTG 最终浓度为0.05-1 mM),培养一定时间(如10-30 h),高效表达重组氨基甲酸乙酯水解酶。Another technical problem solved by the present invention is to provide a method for preparing a recombinant urethane hydrolase, which is prepared by transforming a recombinant expression vector into an expression host to construct an expression system, and culturing and expressing under certain conditions to prepare a recombinant urethane hydrolysis. Enzyme. Wherein, the expression host may be a plant, an animal or a bacterium, and the preferred expression host is Escherichia coli, such as the genetically engineered bacteria obtained as described above: E. coli BL21(DE3)/pET20b(+)-UH. The better method is to use E. coli BL2 (DE3)/pET20b(+)-UH The genetically engineered bacteria are cultured to a certain bacterial concentration (such as OD600=0.35-0.8), and an inducer (such as IPTG final concentration of 0.05-1 mM) is added for a certain period of time (such as 10-30). h), efficient expression of recombinant urethane hydrolase.
附图说明DRAWINGS
图 1 为本发明UH 的PCR 扩增电泳图谱,其中1 为UH 的PCR 扩增产物;2 为DNA Marker(2000 bp,Takara 公司)Figure 1 is a PCR amplification electropherogram of UH of the present invention, wherein 1 is a PCR amplification product of UH; 2 is DNA Marker (2000 bp, Takara company)
图2 为本发明质粒pET20b(+)-UH 的Nde I 和BamH I 双酶切分析图谱,其中,1 为DNA Marker(5000 bp,Takara 公司);2 为pET20b(+)-UH 经Nde I 和BamH I 双酶切电泳。Figure 2 is a double-cut analysis map of Nde I and BamH I of plasmid pET20b(+)-UH of the present invention, wherein DNA Marker (5000 bp, Takara); 2 pET20b(+)-UH was digested by Nde I and BamH I.
图 3 为本发明基因工程菌株E. coli BL21(DE3)/pET20b(+)-UH 表达产物的SDS-PAGE 蛋白电泳图,其中1 为基因工程菌E.coli BL21(DE3)/pET20b(+)-UH 非诱导产物;2 为蛋白分子量标准(碧云天公司);3 为基因工程菌E. coli BL21(DE3)/pET20b(+)-UH 经IPTG 诱导15 小时的产物。Figure 3 is a genetically engineered strain of the present invention E. coli BL21(DE3)/pET20b(+)-UH SDS-PAGE protein electrophoresis map of the expressed product, wherein 1 is a genetically engineered strain E.coli BL21(DE3)/pET20b(+)-UH non-inducing product; It is the protein molecular weight standard (Biyuntian Company); 3 is the product of genetic engineering bacteria E. coli BL21(DE3)/pET20b(+)-UH induced by IPTG for 15 hours.
具体实施方式detailed description
下面用实施例来进一步说明本发明。The invention is further illustrated by the following examples.
下列实施例中的材料与方法:Materials and methods in the following examples:
所采用的分子克隆技术参考 J. 萨姆布鲁克等编的《分子克隆实验指南》。The molecular cloning technique used is referred to J. Sambrook et al., Guide to Molecular Cloning.
所使用的限制性内切酶和胶回收试剂盒均购自 Fermentas 公司,具体的反应条件和使用方法参考其说明书。基因组抽提试剂盒购自Omega 公司,使用参考其说明书。The restriction enzymes and gel recovery kits used were purchased from Fermentas The company, the specific reaction conditions and methods of use refer to its instructions. The genomic extraction kit was purchased from Omega and used with reference to its instructions.
下面的商品化质粒和大肠杆菌用于基因克隆和表达。The following commercial plasmids and E. coli are used for gene cloning and expression.
pMD19-T (Takara, 中国)pMD19-T (Takara, China)
pET20b(+) (Novagen,美国)pET20b(+) (Novagen, USA)
E. coli JM 109 (Novagen, 美国)E. coli JM 109 (Novagen, United States)
E.coli BL21 (DE3) (Novagen, 美国)E.coli BL21 (DE3) (Novagen, United States)
实施例1:从梭形赖氨酸芽孢杆菌基因组中克隆UH 基因Example 1: Cloning of the UH gene from the B. lycopene genome
将在平板上划线活化的梭形赖氨酸芽孢杆菌单菌落接种于 LB 液体培养基,培养约15 h 处于对数生长期时,收集菌体。参考基因组抽提试剂盒步骤,提取其基因组DNA。根据蛋白序列比对结果设计特异性引物,包括正向引物1 和反向引物2,正向引物1 加上Nde I,反向引物2 加上BamH I,如下:A single colony of Bacillus lysine bacillus activated by streaking on a plate was inoculated into LB liquid medium and cultured for about 15 h. In the logarithmic growth phase, the cells are collected. The genomic DNA is extracted by reference to the genomic extraction kit step. Design specific primers based on protein sequence alignment results, including forward primer 1 and reverse primer 2, forward primer 1 Add Nde I, reverse primer 2 plus BamH I, as follows:
正向引物 1:5'-GGA ATT CCA TAT GAT GCG GAC ATT GCT GTA CGT-3'Forward primer 1:5'-GGA ATT CCA TAT GAT GCG GAC ATT GCT GTA CGT-3'
反向引物2:5'-CGG GAT CCT TAG ATA TTA GCA AAA ATA TTT GGT TTT-3'Reverse Primer 2: 5'-CGG GAT CCT TAG ATA TTA GCA AAA ATA TTT GGT TTT-3'
以梭形赖氨酸芽孢杆菌基因组DNA 为模板,上述特异性引物为引物,对UH 酶基因进行扩增。Using the genomic DNA of Bacillus lysosii as a template, the above specific primers are primers, and the UH enzyme gene is amplified.
PCR 扩增使用Takara 公司试剂盒,使用参考其说明书,扩增34 个循环。扩增条件如下:
步骤 温度 时间
1 95℃ 5 min
2 95℃ 30 sec
3 55℃ 30 sec
4 72℃ 100 sec
5 72℃ 10 min
PCR amplification was performed using the Takara kit, and 34 cycles were amplified using the instructions. The amplification conditions are as follows:
step temperature time
1 95 ° C 5 min
2 95 ° C 30 sec
3 55 ° C 30 sec
4 72°C 100 sec
5 72°C 10 min
用0.8%琼脂糖凝胶分离PCR 产物,切胶回收大小越为1.4 kb 的DNA 片段(如图1 所示),通过连接酶将其与pMD19-T 载体连接,构建克隆载体pMD19-T-UH,连接产物转化大肠杆菌JM109,摇瓶培养提取质粒,酶切验证并送上海生工生物公司测定核苷酸序列,得到如核苷酸序列表SEQ ID NO.1 中所示,通过三联体密码子翻译,得到如氨基酸序列表SEQ ID NO.2中所示。The PCR product was separated on a 0.8% agarose gel and the DNA fragment was recovered to a size of 1.4 kb (see Figure 1). Show), by ligase with pMD19-T The vector was ligated, and the cloning vector pMD19-T-UH was constructed. The ligated product was transformed into Escherichia coli JM109, and the plasmid was extracted by shake flask culture. The enzyme was digested and sent to Shanghai Biotech Co., Ltd. to determine the nucleotide sequence, and the nucleotide sequence table was obtained. As shown in ID NO. 1, it is obtained by triplet codon translation as shown in SEQ ID NO. 2 of the amino acid sequence listing.
实施例 2:表达载体和表达体系的构建Example 2: Construction of expression vector and expression system
克隆载体 pMD19-T-UH 和pET20b(+)质粒分别经Nde I 和BamH I 双酶切后,用0.8%琼脂糖凝胶电泳分离酶切产物,并分别回收1.4 kb 和3.7 kb 大小的DNA 片段,经连接酶连接反应,构建 pET20b(+)-UH 表达载体,连接产物转化大肠杆菌BL21 (DE3)感受态细胞,经氨苄青霉素平板筛选得到阳性克隆子,培养提取重组质粒,经Nde I 和BamH I 双酶切验证并送上海生工生物公司测序,证明含有正确的插入片段(如图2 所示),从而得到重组氨基甲酸乙酯水解酶的外源表达体系E. coli BL21(DE3)/pET20b(+)-UH。The cloning vectors pMD19-T-UH and pET20b(+) plasmids were Nde I and BamH I, respectively. After double digestion, the digested products were separated by 0.8% agarose gel electrophoresis, and DNA fragments of 1.4 kb and 3.7 kb were separately recovered, and ligase was ligated to construct pET20b(+)-UH. The expression vector was ligated into E. coli BL21 (DE3) competent cells, and the positive clones were screened by ampicillin plate. The recombinant plasmid was cultured and extracted by Nde I and BamH I. Double enzyme digestion was verified and sent to Shanghai Biotech Co., Ltd. for sequencing, which proved to contain the correct insert (as shown in Figure 2), thus obtaining the exogenous expression system of recombinant urethane hydrolase E. coli BL21(DE3)/pET20b(+)-UH.
实施例 3:氨基甲酸乙酯水解酶的重组表达Example 3: Recombinant expression of urethane hydrolase
挑取基因工程菌 E. coli BL21(DE3)/pET20b(+)-UH 单菌落,接种于25 mL、含有50 μg/mL氨苄青霉素的LB 液体培养基中,37℃震荡培养过夜。第二天按2%接种量转接如上液体培养基中,培养至菌浓OD600=0.6 时,加入IPTG 至终浓度为0.1 mmol/L 诱导,培养15 h,离心收集菌体,通过超声破壁、离心取上清,测定酶活(如文献Zhao C, Kobashi K (1994) Purification and characterization of iron-containing urethanase from Bacillus licheniformis. Biol Pharm Bull 17(6):773-778 中测定酶活的方法)并通过SDS-PAGE 检测蛋白表达量。从图3 中可知,与未连接有目的条带的空载体泳道相比,诱导后泳道在50 kDa 处有与预测大小一致的目标条带,证明重组蛋白在此表达体系中实现了表达,蛋白表达量占总蛋白量的约 20%,酶活力为83.5U/g 湿菌体。Pick a genetically engineered strain E. coli BL21(DE3)/pET20b(+)-UH single colony, inoculated at 25 In mL, LB liquid medium containing 50 μg/mL ampicillin was incubated overnight at 37 °C with shaking. On the next day, transfer to the above liquid medium according to the 2% inoculum, and culture until the concentration of OD600=0.6 When IPTG was added to a final concentration of 0.1 mmol/L, the cells were cultured for 15 h, and the cells were collected by centrifugation, and the supernatant was removed by ultrasonication and centrifugation to determine the enzyme activity (such as the literature Zhao C, Kobashi). K (1994) Purification and characterization of iron-containing urethanase from Bacillus licheniformis. Biol Pharm Bull 17(6): Method for determining enzyme activity in 773-778) and by SDS-PAGE The amount of protein expression was measured. As can be seen from Figure 3, the lanes after induction were 50 kDa compared to the empty vector lanes to which no target bands were ligated. There is a target band consistent with the predicted size, which proves that the recombinant protein is expressed in this expression system, the protein expression amount is about 20% of the total protein amount, and the enzyme activity is 83.5 U/g wet cells.

Claims (7)

1、一种氨基甲酸乙酯水解酶基因,其特征在于: A urethane hydrolase gene characterized by:
1)具有SEQ ID NO: 1 所示的核苷酸序列;1) having the nucleotide sequence shown by SEQ ID NO: 1;
2)编码SEQ ID NO: 2 所示蛋白质。2) Encoding the protein of SEQ ID NO: 2.
2、如权利要求1 所述的氨基甲酸乙酯水解酶基因,其特征在于所述氨基甲酸乙酯水解酶基因源自梭形赖氨酸芽孢杆菌(Lysinibacillus fusiformis)。2. As claimed in claim 1 The urethane hydrolase gene, characterized in that the urethane hydrolase gene is derived from Bacillus lysine (Lysinibacillus) Fusiformis).
3、权利要求1 所述氨基甲酸乙酯水解酶基因编码的蛋白质,氨基酸序列如SEQ ID NO: 2 所示或在SEQ ID NO: 2 所示序列基础上发生一个或几个氨基酸残基的取代、缺失或添加且具有相同酶活性的蛋白质。3. A protein encoded by the urethane hydrolase gene of claim 1, the amino acid sequence of which is set forth in SEQ ID NO: 2 or in SEQ ID NO: A protein in which one or several amino acid residues are substituted, deleted or added and has the same enzymatic activity on the basis of the sequence shown.
4、含有权利要求1 所述氨基甲酸乙酯水解酶基因的重组载体。4. A recombinant vector comprising the urethane hydrolase gene of claim 1.
5、含有权利要求1 所述氨基甲酸乙酯水解酶基因的转基因细胞系。5. A transgenic cell line comprising the urethane hydrolase gene of claim 1.
6、权利要求1 所述氨基甲酸乙酯水解酶基因在制备重组氨基甲酸乙酯水解酶中的应用。6. The use of the urethane hydrolase gene of claim 1 for the preparation of a recombinant urethane hydrolase.
7、利用权利要求1 所述氨基甲酸乙酯水解酶基因构建基因工程菌的方法,包括如下步骤:构建含有所述氨基甲酸乙酯水解酶基因的重组载体,将所述重组载体转化至大肠杆菌中,获得的重组基因工程菌进行诱导培养,培养液分离得到含有重组氨基甲酸乙酯水解酶的菌体细胞。7. Use of claim 1 The method for constructing a genetically engineered bacteria by the urethane hydrolase gene comprises the steps of: constructing a recombinant vector containing the urethane hydrolase gene, transforming the recombinant vector into Escherichia coli, and obtaining a recombinant gene The engineered bacteria are subjected to induction culture, and the culture liquid is separated to obtain a bacterial cell containing the recombinant urethane hydrolase.
PCT/CN2013/090631 2013-09-10 2013-12-27 Ethyl carbamate hydrolase gene and protein encoded thereby and use thereof WO2015035730A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201310411144.1 2013-09-10
CN201310411144.1A CN103451216B (en) 2013-09-10 2013-09-10 Ethyl carbamate hydrolase gene, protein coded thereby and application

Publications (1)

Publication Number Publication Date
WO2015035730A1 true WO2015035730A1 (en) 2015-03-19

Family

ID=49734053

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2013/090631 WO2015035730A1 (en) 2013-09-10 2013-12-27 Ethyl carbamate hydrolase gene and protein encoded thereby and use thereof

Country Status (2)

Country Link
CN (1) CN103451216B (en)
WO (1) WO2015035730A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103451216B (en) * 2013-09-10 2015-06-03 江南大学 Ethyl carbamate hydrolase gene, protein coded thereby and application
CN105420210B (en) * 2015-12-21 2018-08-07 江南大学 The ethyl carbamate hydrolase mutant that thermal stability improves
CN114807102B (en) * 2022-05-16 2023-08-04 安徽工程大学 Ethanol-resistant amidase, gene, expression vector, engineering bacterium, preparation method and application
KR102510304B1 (en) * 2022-07-01 2023-03-22 중앙대학교 산학협력단 Saccharomyces cerevisiae strain with improved ethyl carbamate degradation and uses thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3899080B2 (en) * 2004-03-03 2007-03-28 独立行政法人科学技術振興機構 New uretanase
CN103013948A (en) * 2012-12-27 2013-04-03 江南大学 Method for producing ethyl carbamate enzyme by purifying lysinibacillus fusiformis
CN103074275A (en) * 2012-12-27 2013-05-01 江南大学 Lysinibacillus fusiformis for producing ethyl urethane hydrolase and application of lysinibacillus fusiformis
CN103451216A (en) * 2013-09-10 2013-12-18 江南大学 Ethyl carbamate hydrolase gene, protein coded thereby and application

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3899080B2 (en) * 2004-03-03 2007-03-28 独立行政法人科学技術振興機構 New uretanase
CN103013948A (en) * 2012-12-27 2013-04-03 江南大学 Method for producing ethyl carbamate enzyme by purifying lysinibacillus fusiformis
CN103074275A (en) * 2012-12-27 2013-05-01 江南大学 Lysinibacillus fusiformis for producing ethyl urethane hydrolase and application of lysinibacillus fusiformis
CN103451216A (en) * 2013-09-10 2013-12-18 江南大学 Ethyl carbamate hydrolase gene, protein coded thereby and application

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"glutamyl-tRNA amidotransferase subunit A [Lysinibacillus Fusiformis", NCBI REFERENCE SEQUENCE: WP_004227700.1, 26 May 2013 (2013-05-26) *

Also Published As

Publication number Publication date
CN103451216B (en) 2015-06-03
CN103451216A (en) 2013-12-18

Similar Documents

Publication Publication Date Title
WO2015035730A1 (en) Ethyl carbamate hydrolase gene and protein encoded thereby and use thereof
US9493804B2 (en) Agents and methods for the expression and secretion of peptides and proteins
WO2013027977A2 (en) Composition for breaking down l-asparagine comprising l-asparaginase, and production method for l-asparaginase
Mattiuzzo et al. Proteolytic activity of Escherichia coli oligopeptidase B against proline-rich antimicrobial peptides
EP1689869B1 (en) Recombinant microorganism
Sreenivas et al. Disruption of KEX1 gene reduces the proteolytic degradation of secreted two-chain Insulin glargine in Pichia pastoris
KR102501259B1 (en) A recombinant Corynebacterium having enhanced secreted production efficiency of target protein
US9732331B2 (en) Codon modified amylase from Bacillus akibai
US20100041101A1 (en) Expression system for recombinant human arginase i
EP3301106B1 (en) Strong secretory signal peptide enhancing small peptide motif and use thereof
Soleymani et al. Analysis of methods to improve the solubility of recombinant bovine sex determining region Y protein
WO2020067618A1 (en) L-amino acid-producing microorganism exhibiting increased α-glucosidase activity, and l-amino acid production method using same
KR101837636B1 (en) Secretory production of L-asparaginase in recombinant Corynebacterium
JP5284947B2 (en) Novel amidase, gene thereof, vector, transformant, optically active carboxylic acid amide and method for producing optically active carboxylic acid using them
JP2008271956A (en) Modified microorganism
US11365403B2 (en) Beta-lactamase variants
Ryabchenko et al. Cloning the amidase gene from Rhodococcus rhodochrous M8 and its expression in Escherichia coli
CN113201552B (en) Molecular chaperone plasmid system and application thereof
CN110564662A (en) Construction method of integrated bacillus subtilis for efficiently expressing acetaldehyde dehydrogenase
Chan Expression and purification of recombinant lysostaphin in Escherichia coli
CN113957071B (en) Combined DNA fragment with double promoter and double secretion signal functions and application thereof
WO2012128661A1 (en) Fusion protein, fusion protein-producing strain of escherichia coli bacteria and a method for producing methionine-free human interferon alpha-2b from said fusion protein
JP5829802B2 (en) Recombinant Bacillus subtilis
Kavitha et al. Cloning and molecular characterisation of resuscitation promoting factor-like gene from Mycobacterium avium subspecies avium
JP2010207168A (en) Asparaginase

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13893629

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13893629

Country of ref document: EP

Kind code of ref document: A1